Article
Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway.
Future microbiology - 1 Dec 2011
Mark Brian L, Vocadlo David J, Oliver Antonio
Abstract excerpt
A major cause of the clinical failure of broad-spectrum β-lactam antibiotics against Pseudomonas aeruginosa and many Enterobacteriaceae species are chromosomal mutations that lead to the hyperproduction of AmpC β-lactamase. These mutations typically affect proteins within the peptidoglycan (PG) recycling pathway, as well as proteins that are modulated by metabolic intermediates of this pathway. Blocking PG...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
